Medicare Enrolled
Dr. Dean Sutherland, MD
Neurology · Sarasota, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sutherland from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sutherland?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sutherland
Dr. Dean Sutherland is a neurology specialist in Sarasota, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sutherland performed 26,720.5 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Sutherland received a total of $53,171 from 60 pharmaceutical and/or device companies across 509 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sutherland is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 4% volume in FL
$53,171 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 79474 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗26,720.5
Medicare services
Top 4% in FL for neurology
Not available
Unique patients (not deduplicated)
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
22,792.5 | $5 | $10 |
| Rimabotulinumtoxinb injection, 100 units An injection of rimabotulinumtoxinb administered in a dose of 100 units. |
1,300 | $10 | $24 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,287 | $90 | $219 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
384 | $60 | $151 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
173 | $133 | $294 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
79 | $128 | $415 |
| New patient office visit, complex (60-74 min) | 78 | $157 | $421 |
| Brain stimulator programming, first 15 minutes Electronic analysis of an implanted brain, spinal cord, or peripheral neurostimulator generator. This service includes programming the brain stimulator by a qualified health professional for the first 15 minutes. |
74 | $38 | $107 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
74 | $97 | $283 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
68 | $152 | $259 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
62 | $115 | $333 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
49 | $63 | $148 |
| Brain stimulator programming, additional 15 minutes Electronic analysis and programming of an implanted brain neurostimulator generator by a qualified health professional. This code applies to each additional 15-minute increment beyond the initial service. |
47 | $34 | $93 |
| Chemical paralysis of salivary glands, bilateral Injection of a chemical agent to paralyze the salivary glands on both sides of the mouth. |
46 | $102 | $262 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
46 | $37 | $108 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
39 | $124 | $306 |
| Chemical nerve block injection, 1-4 muscles An injection of a chemical agent to paralyze specific muscles in an arm or leg. This procedure targets one to four muscles in the first extremity treated. |
35 | $114 | $288 |
| Electronic analysis of implanted neurostimulator Electronic evaluation of an implanted brain, spinal cord, or peripheral nerve stimulator device. |
35 | $12 | $109 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
20 | $37 | $118 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
16 | $74 | $217 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
16 | $94 | $213 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$53,171
Total received (2018-2024)
Avg $7,596/year across 7 years
Top 8% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
509
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,588
2023
$1,522
2022
$5,257
2021
$11,145
2020
$17,283
2019
$1,588
2018
$14,789
Payments by company (2024)
ABBVIE INC.
$619
Abbott Laboratories
$318
Kyowa Kirin, Inc.
$74
Neurocrine Biosciences, Inc.
$71
Alexion Pharmaceuticals, Inc.
$66
PFIZER INC.
$46
Lundbeck LLC
$43
Takeda Pharmaceuticals U.S.A., Inc.
$42
CATALYST PHARMACEUTICALS, INC.
$38
Amneal Pharmaceuticals LLC
$35
MITSUBISHI TANABE PHARMA AMERICA, INC.
$35
Acorda Therapeutics, Inc
$26
REVANCE THERAPEUTICS, INC.
$24
Merz Pharmaceuticals, LLC
$24
UCB, Inc.
$23
Teva Pharmaceuticals USA, Inc.
$22
InSightec,Inc
$22
MDD US Operations, LLC
$21
Neurelis, Inc.
$20
Otsuka America Pharmaceutical, Inc.
$19
Top 3 companies account for 63.7% of 2024 payments
All-time payments by company (2018-2024) ›
Amneal Pharmaceuticals LLC
$12,875
Acorda Therapeutics, Inc
$11,668
US WorldMeds, LLC
$7,278
Sunovion Pharmaceuticals Inc.
$7,150
Teva Pharmaceuticals USA, Inc.
$6,533
ABBVIE INC.
$900
UCB, Inc.
$676
Neurocrine Biosciences, Inc.
$494
AbbVie Inc.
$487
Abbott Laboratories
$473
Alexion Pharmaceuticals, Inc.
$435
Adamas Pharmaceuticals, Inc.
$336
Allergan Inc.
$322
ACADIA Pharmaceuticals Inc
$278
GE HealthCare
$263
Novartis Pharmaceuticals Corporation
$240
Kyowa Kirin, Inc.
$198
GE HEALTHCARE
$194
Allergan, Inc.
$184
InSightec,Inc
$171
Amgen Inc.
$144
Takeda Pharmaceuticals U.S.A., Inc.
$140
AbbVie, Inc.
$139
AstraZeneca Pharmaceuticals LP
$114
SK Life Science, Inc.
$103
PFIZER INC.
$98
CATALYST PHARMACEUTICALS, INC.
$95
Lundbeck LLC
$87
Medtronic USA, Inc.
$81
Biohaven Pharmaceutical Holding Company Ltd.
$76
Greenwich Biosciences, Inc.
$72
Alnylam Pharmaceuticals Inc.
$69
Supernus Pharmaceuticals, Inc.
$65
Neurelis, Inc.
$49
Horizon Therapeutics plc
$46
MITSUBISHI TANABE PHARMA AMERICA, INC.
$46
ARGENX US, INC.
$46
PORTOLA PHARMACEUTICALS, INC.
$44
MDD US Operations, LLC
$42
Avion Pharmaceuticals
$42
Amylyx Pharmaceuticals, Inc.
$34
Lilly USA, LLC
$33
Avanir Pharmaceuticals, Inc.
$31
Corium, LLC
$30
Akcea Therapeutics, Inc.
$29
REVANCE THERAPEUTICS, INC.
$24
Merz Pharmaceuticals, LLC
$24
Egalet US Inc
$22
Otsuka America Pharmaceutical, Inc.
$19
Biohaven Pharmaceuticals, Inc.
$18
Grifols USA, LLC
$18
Biogen, Inc.
$18
Boston Scientific Corporation
$17
Mitsubishi Tanabe Pharma America, Inc.
$16
EISAI INC.
$16
Bausch Health US, LLC
$15
Ultragenyx Pharmaceutical Inc.
$15
Impax Laboratories, Inc.
$15
GRT US Holding, Inc.
$13
Zyla Life Sciences, Inc.
$13
Top 3 companies account for 59.8% of all-time payments
Associated products mentioned in payments ›
ACTIVA · ADLARITY · AFINITOR · AIMOVIG · AJOVY · AMYVID · ANDEXXA · APOKYN · APTIOM · AUSTEDO · Aimovig · Austedo XR · BEVYXXA · BOTOX · BOTOX THERAPEUTIC · Briviact · COPAXONE · DAXXIFY · DUOPA · Dhivy · Duopa · EMGALITY · Epidiolex · Exablate · FIRDAPSE · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Gocovri · HYQVIA · INBRIJA · INFINITY · INGREZZA · KYNMOBI · LYRICA · MIGRANAL · MYOBLOC · NAMZARIC · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OXTELLAR XR · Ongentys · PAXLOVID · QULIPTA · Qutenza · RADICAVA · RELYVRIO · REXULTI · RYTARY · Radicava · SOLIRIS · SPINRAZA · SPRIX · SPYGLASS RETRIEVAL BASKET · Soliris · Strensiq · TEGSEDI · TROKENDI XR · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VIIBRYD · VYALEV · VYEPTI · VYVGART · Vimpat · XCOPRI · Xadago · Xeomin · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
37
County median income
$80,633
Nearest hospital to ZIP centroid (approximate)
SARASOTA MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sutherland is a mixed practice specialist, with above-average Medicare volume (top 4% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sutherland experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Sutherland performed 22,792.5 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sutherland receive payments from pharmaceutical companies?
Yes. Dr. Sutherland received a total of $53,171 from 60 companies across 509 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sutherland's costs compare to other neurologists in Sarasota?
Dr. Sutherland's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sutherland) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Sarasota
Browse neurologists in Sarasota ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
By company
Amneal Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Amneal Pharmaceuticals LLC.
By company
Acorda Therapeutics, Inc Payments to Doctors
See all physicians who received payments from Acorda Therapeutics, Inc.
By company
US WorldMeds, LLC Payments to Doctors
See all physicians who received payments from US WorldMeds, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology